Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.00 from other evidence | 0.00 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | a small-molecule pocket | 0.60 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 2 Parkinson's papers of 24 | 0.85 |
| pathways Reactome | 4 pathways; mostly mitochondrial quality control | 1.00 |
No case: the score is under the bar. Receipt 13664
Sealed predictions
- MRPL44 in dopamine neurons, braak+0.60 (p 0.086) → +0.27 (p 0.484)receipt 13671
Swarm cases
receipt 13671: MRPL44 in dopamine neurons, braak
- power
- full sample +0.47 (p 0.049, n 18), 95% CI +0.01 to +0.77. the interval excludes zero: something may be there, smaller than a half can see.
- confounder
- adjusted for sex: +0.46 (p 0.052, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.42 (p 0.082, n 18). could be the mix.
- skeptic
- leave-one-out range +0.39 to +0.57, sign flips 0; without severely affected donors +0.47 (p 0.049, n 18). robust.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for MRPL44 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts